Lord, Abbett & Co. LLC Axonics, Inc. Transaction History

Lord, Abbett & Co. LLC

$31.6 Billion
Q4 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 07, 2024	BUY	$49.38 - $63.75 $3.41 Million - $4.4 Million	69,003 Added 73.62%	162,726 $10.1 Million
Q4 2023 Feb 12, 2024	BUY	$49.38 - $63.75 $3.41 Million - $4.4 Million	69,003 Added 73.62%	162,726 $10.1 Million
Q3 2023 Oct 07, 2024	SELL	$48.64 - $62.51 $16.9 Million - $21.7 Million	-347,337 Reduced 78.75%	93,723 $5.26 Million
Q3 2023 Nov 13, 2023	SELL	$48.64 - $62.51 $16.9 Million - $21.7 Million	-347,337 Reduced 78.75%	93,723 $5.26 Million
Q2 2023 Oct 07, 2024	SELL	$47.99 - $60.21 $41.8 Million - $52.4 Million	-870,619 Reduced 66.37%	441,060 $22.3 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $41.8 Million - $52.4 Million	-870,619 Reduced 66.37%	441,060 $22.3 Million
Q1 2023 Oct 07, 2024	SELL	$52.6 - $67.34 $18.8 Million - $24.1 Million	-357,313 Reduced 21.41%	1,311,679 $71.6 Million
Q1 2023 May 12, 2023	SELL	$52.6 - $67.34 $18.8 Million - $24.1 Million	-357,313 Reduced 21.41%	1,311,679 $71.6 Million
Q4 2022 Oct 07, 2024	BUY	$59.56 - $76.6 $99.4 Million - $128 Million	1,668,992 New	1,668,992 $104 Million
Q4 2022 Feb 10, 2023	SELL	$59.56 - $76.6 $12.1 Million - $15.5 Million	-202,882 Reduced 10.84%	1,668,992 $104 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $35.4 Million - $47.7 Million	611,091 Added 48.47%	1,871,874 $132 Million
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $690,025 - $1.13 Million	17,469 Added 1.41%	1,260,783 $71.4 Million
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $12.4 Million - $17.8 Million	-283,135 Reduced 18.55%	1,243,314 $77.8 Million
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $10.5 Million - $15.3 Million	-209,149 Reduced 12.05%	1,526,449 $85.5 Million
Q3 2021 Nov 09, 2021	SELL	$59.21 - $78.66 $17.6 Million - $23.4 Million	-297,654 Reduced 14.64%	1,735,598 $113 Million
Q2 2021 Aug 11, 2021	SELL	$51.39 - $66.9 $1.19 Million - $1.55 Million	-23,162 Reduced 1.13%	2,033,252 $129 Million
Q1 2021 May 11, 2021	BUY	$49.14 - $59.89 $26.4 Million - $32.1 Million	536,615 Added 35.31%	2,056,414 $123 Million
Q4 2020 Feb 09, 2021	BUY	$42.19 - $51.5 $10.5 Million - $12.8 Million	248,275 Added 19.53%	1,519,799 $75.9 Million
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $11.8 Million - $17 Million	333,016 Added 35.48%	1,271,524 $64.9 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $3.11 Million - $5.41 Million	135,877 Added 16.93%	938,508 $33 Million
Q1 2020 May 14, 2020	BUY	$16.44 - $37.73 $8.11 Million - $18.6 Million	493,527 Added 159.66%	802,631 $20.4 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $30,842 - $45,640	1,576 Added 0.51%	309,104 $8.57 Million
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $2.64 Million - $4.15 Million	97,923 Added 46.72%	307,528 $8.28 Million
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $3.89 Million - $8.59 Million	209,605 New	209,605 $8.59 Million

Others Institutions Holding AXNX

# of Institutions

Shares Held

5.03M

Call Options Held

Put Options Held

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account